Risk Factors for Colonisation or Infection with Carbapenem Resistant Escherichia Coli and Klebsiella Pneumoniae

Objective: Since 1991, carbapenem resistance is being reported in an increasing fash- ion worldwide. It is expected to increase due to increasing frequency of international travels. Carbapenem resistant Escherichia coli and Klebsiella pneumoniae can cause colonization or clinical infection. Treatment of carbapenem resistant Escherichia coli or Klebsiella pneumoniae is not precise and we have limited choices of antibiotics. This brings increasing morbidity and mortality with itself. We aimed to find out risk factors for colonization or infection with carbapenem resistant Escherichia coli and Klebsiella pneumoniae in this study. Materials and Methods: With the decision of Adult Hospital Infection Control Comittee, a surveillance has been started among adult patients (>18 years of age) at Hacettepe University Hospitals at June 2009. A perianal swab culture has been obtained weekly by Adult Hospital Infection Control nurses from patients includ- ed in surveillance program. In this study, carried on adult patients hospitalized at Hacettepe University hospitals between 01.06.2009-31.12.2010, risk factors for col- onization or infection with carbapenem resistant Escherichia coli and Klebsiella pneumoniae, those are detected via surveillance cultures or clinical specimens, were investigated. Results: According to results of the multivariate analysis of the study; being hospital- ized in an internal ward (any ward other than a surgical ward) (p=0,005), Diabetes Mellitus (p=0,010), immunosuppression (p

Kaynakça

McConville TH, Sullivan SB, Gomez-Simmonds A, et al. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortali- ty in critically ill patients, an observational study. PLoS One 2017; 12(10): e0186195.

Hong T, Moland ES, Abdalhamid B, et al. Escherichia coli: de- velopment of carbapenem resistance during therapy. Clin Infect Dis 2005; 40(10): e84-6.

MacKenzie FM, Forbes KJ, Dorai-John T, et al. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 1997; 350: 783. Hussein K, Sprecher H, Mashiach T, et al. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009; 30(7): 666-71.

Falagas ME, Rafailidis PI, Kofteridis D, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 2007; 60(5): 1124-30.

Hoban DJ, Bouchillon SK, Hawser SP, et al. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn Microbiol Infect Dis 2010; 66(1): 78-86.

Kwak YG, Choi SH, Choo EJ, et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 2005; 11(2): 165-9.

Leavitt A, Navon-Venezia S, Chmelnitsky I, et al. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneu- moniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007; 51(8): 3026-9.

Hossain A, Ferraro MJ, Pino M, et al. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob Agents Chemother 2004; 48(11): 4438-40.

Marra AR, Pereira CA, Gales AC, et al. Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother 2006; 50(1): 388-90.

Souli M, Kontopidou FV, Papadomichelakis E, et al. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lact- amase in a Greek University Hospital. Clin Infect Dis 2008; 46(6): 847-54.

Hirakata H, Izumikawa K, Yamaguchi T, et al. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother 1998; 42(8): 2006-11.

Hancock RE. Resistance mechanisms in pseudomonas aeroginosa and other nonfermentative gram negative bacteria. Clin Infect Dis 1998; 27(1): 93-9.

Duygu G. Gram negatif bakterilerde antibakteriyel direnç mekanizmaları, önemli ve sorunlu gram negatif bakteri infek- siyonları. 3. ed. İzmir; Palme Yayınevi, 2004; 69-83.

Pitout JD, Gregson DB, Poirel L, et al. Detection of Pseudomonas aeruginosa producing metallo-beta-lact- amases in a large centralized laboratory. J Clin Microbiol 2005; 43(7): 3129-35.

Turton JF, Ward ME, Woodford N, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258(1): 72-7.

Potter RF, D’SouzaA, Dantas G. The rapid spread of carbap- enem-resistant Enterobacteriaceae. Drug Resist Updat 2016; 29: 30-46.

Guidance for Control of Infections with Carbapenem- Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilitiess. CDC 2009; 58 (10): 256-260.

Wu UI, Wang JL, Chen WC, et al. Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases. Eur J Clin Microbiol Infect Dis 2011; 30(1): 33-9.

Salomão MC, Duailibi DF, Perondi MBM, et al. Carbapenem- resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate. J Hospt Infect 2017; 97(3): 241-246 .

Hussein K, Sprecher H, Mashiach T, et l. Carbapenem resistance among Klebsiella pneumonia Isolates: Risk Factors, Molecular Characteristics, and Susceptibility Patterns. Infect Control Hosp Epidemiol 2009; 30(7): 666-71.

Kaynak Göster